Studies from Saarland University Reveal New Findings on Antihyperlipidemic Agents (Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells).

Antihyperlipidemic Agents, Carboxylic Acids, Clofibric Acid, Drugs and Therapies, Fibric Acid Derivatives, Gemfibrozil, Gemfibrozil Therapy, Health and Medicine, Organic Chemicals, Pentanoic Acids, Pharmaceuticals According to news originating from Homburg, Germany, by NewsRx editors, the research stated, "Gemfibrozil is a drug that has been used for over 40 years to lower triglycerides in blood." Keywords: Antihyperlipidemic Agents; Carboxylic Acids; Clofibric Acid; Drugs and Therapies; Fibric Acid Derivatives; Gemfibrozil; Gemfibrozil Therapy; Health and Medicine; Organic Chemicals; Pentanoic Acids; Pharmaceuticals EN Antihyperlipidemic Agents Carboxylic Acids Clofibric Acid Drugs and Therapies Fibric Acid Derivatives Gemfibrozil Gemfibrozil Therapy Health and Medicine Organic Chemicals Pentanoic Acids Pharmaceuticals 2458 2458 1 03/24/23 20230228 NES 230228 2023 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on antihyperlipidemic agents have been published. [Extracted from the article]